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Abstract 
Lignans	  are	  naturally	  occurring	  compounds,	  polyphenolic	  secondary	  plant	  and	  mammalian	   metabolites.	   Due	   to	   their	   ubiquitous	   presence	   and	   biological	  activity,	   lignans	   have	   attracted	   the	   interest	   of	   scientists	   from	   different	   areas,	  like	   nutrition	   scientists,	   pharmaceutical	   researchers	   and	   synthetic	   chemists.	  The	  research	   is	  very	  active,	  and	  the	  number	  of	   lignan	  related	  publications	  has	  proliferated.	  Lignans	  vary	  widely	   in	   the	  structure,	  and	   the	  present	  work	   focuses	  mainly	  on	   the	   (hydroxy)lignano-­‐9,9’-­‐lactones,	   their	   rearranged	   products,	   and	   9,9’-­‐epoxylignanes.	   The	   literature	   review	   introduces	   the	   stereochemistry	   and	  assignment	   of	   the	   absolute	   configuration	   of	   these	   lignans.	   In	   addition,	   stable	  isotope	  labelling	  of	  lignans	  is	  reviewed.	  The	   experimental	   part	   is	   focused	   on	   deuteration	   of	   lignans	   and	  rearrangement	  and	  stereochemistry	  studies.	  The	  deuteration	  reaction	  utilising	  acidic	  H/D	  exchange	  within	   the	   lignan	  skeleton	  was	   investigated.	  The	   relative	  reactivity	   of	   various	   aromatic	   sites,	   the	   stability	   of	   deuterium	   labels	   and	   the	  isotopic	   purity	   of	   the	   labelled	   compounds	   were	   examined.	   Experimental	  observations	   and	   results	   were	   compared	   to	   computational	   studies.	   Several	  stable,	   isotopically	   pure	   polydeuterated	   lignano-­‐9,9’-­‐lactones	   and	   9,9’-­‐epoxylignanes	   were	   synthesised.	   Alongside	   the	   deuteration	   experiments	  unexpected	   reactivity	   in	   eletrophilic	   aromatic	   deuteration	   of	   methylenedioxy	  substituted	  compounds	  was	  observed	  and	  further	  studied.	  In	   addition	   to	   deuteration,	   the	   stereochemistry	   of	   certain	   rearranged	  lignanolactones	   was	   a	   central	   subject	   of	   this	   study.	   Our	   findings	   allowed	   to	  clarify	   some	   mechanistical	   aspects	   of	   the	   rearrangement	   reactions	   of	   7’-­‐hydroxylignano-­‐9,9’-­‐lactones	   and	   revise	   certain	   disputable	   structural	   data	   in	  the	   literature.	   Furthermore,	   the	   X-­‐ray	   structures	   of	   7’-­‐hydroxylignano-­‐9,9’-­‐lactones	  and	  rearranged	  9’-­‐hydroxylignano-­‐9,7’-­‐lactones	  were	  obtained	  for	  the	  first	  time.	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Ac	   acetyl	  aq.	   aqueous	  Ar	   aryl	  bmim	   1-­‐butyl-­‐3-­‐methylimidazolium	  Bn	   benzyl	  Bu,	  n-­‐Bu	   butyl,	  normal	  butyl	  
t-­‐Bu	   tert-­‐butyl	  COSY	   correlation	  spectroscopy	  d.e.	   diastereomeric	  excess	  DMF	   N,N-­‐dimethylformamide	  DMI	   1,3-­‐dimethyl-­‐2-­‐imidazolidinone	  DMPU	   1,3-­‐dimethyl-­‐3,4,5,6-­‐tetrahydro-­‐2(1H)-­‐pyrimidinone	  DP	   dirigent	  protein	  e.e.	   enantiomeric	  excess	  EI	   electron	  ionisation	  (or	  electron	  impact)	  ESI	   electrospray	  ionisation	  ESP	   electrostatic	  potential	  Et	   ethyl	  GC	   gas	  chromatography	  Glu	   glucoside	  (HP)LC	   (high-­‐performance)	  liquid	  chromatography	  ID	   isotope	  dilution	  ip	   isotopic	  purity	  IUPAC	   International	  Union	  of	  Pure	  and	  Applied	  Chemistry	  IR	   infrared	  LC	   liquid	  chromatography	  LDA	   lithium	  diisopropylamide	  LHMDS	   lithium	  hexamethyl	  disilazide	  Me	   methyl	  MS	   mass	  spectrometry	  MW	   microwave	  NMR	   nuclear	  magnetic	  resonance	  NOESY	   nuclear	  overhouse	  effect	  spectroscopy	  Piv	   pivaloyl	  Ph	   phenyl	  Py	   pyridine	  rt	   room	  temperature	  SID	   stable	  isotope	  dilution	  SIM	   selected	  ion	  monitoring	  TBAF	   tetra-­‐n-­‐butylammonium	  fluoride	  TBDMS	   tert-­‐butyldimethylsilyl	  THF	   tetrahydrofuran	  TIPS	   triisopropylsilyl	  TMEDA	   tetramethylethylenediamine	  TMS	   trimethylsilyl	  Ts	   tosyl	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1.3 Numbering and nomenclature Over	  the	  years	  a	  variety	  of	  different	  numbering	  and	  nomenclature	  systems	  have	  been	   used	   for	   lignan	   compounds.	   At	   first,	   lignans	  were	   given	   trivial	   or	   semi-­‐systematic	  names.	  With	   the	   increase	  of	   study	  and	   the	  number	  of	   isolated	  and	  synthetic	  structures,	  similar	   lignans	  have	  been	  named	  differently.	  Very	  similar	  names	  were	   given	   to	   different	   compounds,	   or	   one	   compound	   has	   been	   given	  several	   names.	   This	   has	   caused	  misunderstandings	   and	  mistakes.	   The	   IUPAC	  recommendations	   for	   the	   nomenclature	   of	   lignans	   and	   neolignans26	   brought	  back	  the	  first	  reasonable	  effort	  for	  a	  nomenclature	  system	  by	  Freudenberg	  and	  Weinges	   in	   1961.30	   They	   suggested	   that	   the	   phenylpropane	   units	   should	   be	  numbered	  from	  1–9	  (the	  left	  half	  of	  the	  molecule)	  and	  1’–9’	  (the	  right	  half	  of	  the	  molecule,	   as	   shown	   in	  1,	   Figure	   2),	   where	   the	   8–8’-­‐linkage	   is	   assigned	   to	   all	  lignan	   classes	   according	   to	   the	   definition.	  However,	   the	   numbering	   depended	  on	   how	   the	   lignan	  was	   drawn,	  which	  made	   the	   scheme	   confusing.	   Ayres	   and	  Loike8	  amplified	  the	  system	  by	  proposing	  the	  use	  of	  unprimed	  locants	  for	  that	  half	  of	   the	  molecule	  which	  contained	  functionalities	  with	  priority	  according	  to	  IUPAC	   (structures	   5,	   7	   and	   11	   in	   Figure	   4).	   In	   case	   of	   equivalent	   aliphatic	  chains,	   aromatic	   substituents	   are	   taken	   into	   account.	   In	   this	   thesis	   the	   IUPAC	  general	   alphabetical	   order	   of	   prefixes33	   is	   preferred	   instead	   of	   the	   system	   of	  prioritised	  aryl	  groups	  of	  Ayres	  and	  Loike.8	  In	  the	  early	  review	  of	  natural	  resins	  by	  Haworth,25	  the	  original	  spelling	  was	  lignane,	  but	  the	  “e”	  was	  deleted	  in	  subsequent	  publications.	  However,	  the	  IUPAC	  recommendation	  on	  the	  nomenclature	  of	   lignans	  partly	  reinstated	   it:	   the	  class	  names	  lignan	  and	  neolignan	  are	  still	  spelled	  in	  the	  conventional	  way	  without	  a	  terminal	  “e”,	  but	  the	  parent	  structures	  below	  are	  spelled	  with	  a	  terminal	  “e”	  to	  indicate	  a	  saturated	  chain.	  The	  presence	  of	  a	  double	  or	  a	  triple	  bond	  in	  the	  side	  chain	  is	  indicated	  by	  changing	  the	  -­‐ane	  ending	  to	  -­‐ene	  (structure	  12	  in	  Figure	  4)	  or	  -­‐yne	  with	  the	   locant	  to	   indicate	  the	  position	  of	  the	  double	  or	  triple	  bond.	   If	  there	   are	   two	   double	   bonds	   then	   the	   -­‐ane	   ending	   is	   changed	   to	   -­‐diene	   with	  retention	  of	  the	  “a”	  (13	  in	  Figure	  4).26	  IUPAC	   recommendations	   for	   naming	   of	   different	   lignan	   skeletons	   are	  presented	   in	  Figure	  4.	  Although	  a	  consistent	  nomenclature	   is	  now	  available,	   it	  takes	   time	   before	   it	   becomes	   generally	   accepted	   and	   permeates	   throught	   the	  whole	  field.	  The	  trivial	  names	  of	  naturally	  occurring	  lignans	  are	  still	  commonly	  used	  in	  literature,	  and	  will	  be	  used	  also	  in	  this	  thesis,	  when	  they	  do	  not	  lead	  to	  misunderstanding.	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resolve	   the	   structural	   and	   stereochemical	   problems.	   However,	   despite	   the	  advanced	  spectroscopic	  techniques,	  the	  process	  of	  structure	  assignment	  is	  still	  a	  tricky	  task	  in	  many	  cases,	  even	  with	  relatively	  simple	  structures	  like	  lignans,	  and	  mistakes	  are	  a	  relatively	  common	  occurrence.40,41	  In	   the	   early	   nomenclature	   system	   of	   Freudenberg	   and	   Weinges,	   it	   was	  proposed	   that	   the	  stereochemistry	  could	  be	  expressed	  with	   the	  description	  α,	  when	  hydrogen	  atom	   is	  pointing	  up	   from	   the	  plane,	   and	  β,	  when	  hydrogen	   is	  pointing	   down.30	   Unfortunately,	   this	   symbolism	   is	   prone	   to	   errors,	   since	   it	  requires	   the	   molecules	   to	   be	   drawn	   according	   to	   specific	   rules.	   To	   avoid	  misunderstandings,	  Ayres	  and	  Loike	  recommended	  the	  use	  of	  the	  unambiguous	  Cahn–Ingold–Prelog	   R/S	   system42,43	   to	   express	   the	   absolute	   configurations,8	  and	   it	   is	   preferred	   also	   in	   this	   thesis	   and	   in	   the	   original	   articles,	   even	   if	   the	  IUPAC	   recommendations	   brought	   back	   the	   signs	   α	   and	   β,	   which	   again	   has	  certain	   demands	   on	   how	   the	   molecule	   must	   be	   drawn.26	   The	   IUPAC	  recommendations	   in	   using	   descriptions	   α	   and	   β	   are	   different	   from	   the	   early	  nomenclature	  system	  of	  Freudenberg	  and	  Weinges:	  now	  the	  descriptors	  α	  and	  β	  refer	  to	  the	  location	  of	  a	  bridgehead	  or	  ring	  hydrogen	  or	  substituent	  below	  or	  above	  the	  plane	  of	  the	  molecules,	  respectively.	  As	  also	  the	  drawing	  instructions	  are	  different	  between	  these	  two	  systems,	  the	  stereochemistry	  descriptors	  for	  a	  certain	   chiral	   carbon	   in	   e.g.	   a	   lignano-­‐9,9’-­‐lactone	   (5)	   structure	   may	   differ	  depending	  on	  which	  nomenclature	  system	  is	  used.	  
2.2 Stereochemistry at carbons 8 and 8’ The	   proposed	   8,8’-­‐trans	   configuration	   of	   natural	   lignano-­‐9,9’-­‐lactones	  	  (–)-­‐matairesinol	  and	  (–)-­‐hinokinin44	  was	   initially	  confirmed	  by	  reduction	  with	  LiAlH4	   to	   optically	   active	   diols.45	   If	   the	   compounds	   had	   possessed	   the	   cis	  configuration,	  the	  reduction	  would	  have	  led	  to	  optically	  inactive	  meso-­‐products.	  Dimethyl	   guaiaretic	   acid	   (–)-­‐15	   was	   the	   first	   lignan	   whose	   absolute	  configuration	  was	  determined	   in	  1957.	  The	  absolute	   configuration	  of	   the	   sole	  chiral	   carbon	   was	   determined	   by	   Schrecker	   and	   Hartwell	   by	   relating	   it	  chemically	  to	  L-­‐(S)-­‐3,4-­‐dihydroxyphenylalanine	  (–)-­‐16	  (Scheme	  1).37	  Two	  years	  earlier	   they	   had	   demonstrated	   that	   matairesinol	   (–)-­‐17,	   secoisolariciresinol	  	  (–)-­‐18	  and	  dihydroguaiaretic	  acid	  (–)-­‐19	  related	  to	  the	  absolute	  configuration	  of	  dimethyl	  guaiaretic	  acid	  (–)-­‐15.46	  The	   absolute	   configurations	   of	   the	   bridge	   carbons	   (8	   and	   8’)	   of	   furofuran	  lignans	  were	  resolved	  through	  conversions:	  catalytic	  hydrogenation	  of	  the	  three	  dextrorotatory	   diastereomers	   (+)-­‐20a–c	   led	   to	   levorotatory	   dihydrocubebin	  	  (–)-­‐21	   (Scheme	   2),47	   which	   had	   the	   same	   absolute	   configuration	   as	  secoisolariciresinol	   (–)-­‐18.48	   In	   Scheme	   3	   the	   correlation	   between	   optical	  rotation,	  absolute	  configuration	  and	  various	   lignan	  skeletal	  oxidation	   levels	  of	  the	  guaiacyl	  substituted	  (8R,8’R)-­‐lignans	  are	  shown.	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inferred	   to	  be	   levorotatory.49	  The	  absolute	  configuration	  of	   the	  corresponding	  veratryl	   substituted	   analog	   (–)-­‐galbelgin	  27	   was	   elucidated	   by	   Birch	   et	   al.	   in	  1958.50	   Eventually,	  when	   the	   structure	   of	   fragransin	  A2	  26	  was	   later	   isolated	  (from	   species	   Myristica	   fragrans)	   in	   1987,51	   the	   isolated	   lignan	   was	   the	  	  (+)-­‐enantiomer,	   but	   it	   was	   erroneuosly	   linked	   to	   the	   stereochemistry	   of	  	  (–)-­‐galbelgin.50	   The	   wrong	   stereochemical	   assignment51,52	   was	   not	   corrected	  until	  2007	  by	  enantioselective	   synthesis,53	  but	   for	  example	  Reaxys,	   the	  online	  version	   of	   Beilstein	   Crossfire	   database,	   still	   gives	   the	   wrong	   stereochemical	  information	   in	   search.	   The	   confusions	   are	   problematic,	   since	   an	   occasional	  reader	  or	  a	  newcomer	  in	  the	  lignan	  field	  is	  easily	  led	  astray.	  A	  correlation	  between	  physical	  data	  (optical	  rotation	  and	  NMR	  data)	  and	  the	  absolute	  stereochemistry	  is	  observed.	  Thus,	  when	  the	  relative	  stereochemistry	  (cis	   or	   trans)	   at	   carbons	   8	   and	   8’	   is	   determined,	   e.g.	   with	   the	   help	   of	   NOESY	  correlation,	  the	  absolute	  configuration	  may	  be	  assigned,	  if	  the	  sign	  of	  the	  optical	  rotation	  is	  known.	  For	  instance	  levorotatory	  (–)-­‐enantiomers	  of	  the	  8,8’-­‐trans-­‐	  dibenzylbutane-­‐9,9’-­‐diols,	  8,8’-­‐trans-­‐9,9’-­‐epoxylignanes,	  and	  8,8’-­‐trans-­‐lignano-­‐9,9’-­‐lactones	  have	  been	  shown	  to	  possess	  the	  same	  absolute	  R,R	   configuration	  at	  C-­‐8	  and	  C-­‐8’	  with	  respect	  to	  carbon	  skeleton,54,55	  	  while	  the	  (8S,8’S)-­‐isomers	  are	  dextrorotatory.55,56,57	  The	  less	  common	  cis-­‐structures	  (8S,8’R)-­‐lignano-­‐9,9’-­‐lactones	   are	   dextrorotatory,58,59,60	   whereas	   the	   (8R,8’S)-­‐lignano-­‐9,9’-­‐lactones	  are	  levorotatory.60,61,62*	  When	  more	  chiral	  carbons	  are	  involved,	  the	  comparison	  becomes	  more	  complicated	  but	  nonetheless	  is	  possible.	  
2.3 Stereochemistry at carbons 7 and 7’ For	  natural	  lignans,	  the	  substituents	  at	  carbons	  7	  and	  7’	  are	  hydroxy	  or	  alkoxy	  groups.	   The	   stereochemistry	   at	   C-­‐7	   for	   naturally	   occurring	   7-­‐hydroxylignano-­‐9,9’-­‐lactone	   podorhizol	   (7S)-­‐28a	   was	   established	   as	   S	   already	   in	   1967.	   The	  configuration	  was	  deduced	  from	  the	  existence	  of	  a	  hydrogen	  bond	  between	  the	  hydroxyl	   and	   the	   lactone	   carbonyl,	   possible	   for	   one	   enantiomer	   only	   (Figure	  7).63	  However,	  the	  stereochemistry	  at	  C-­‐7’	  has	  been	  uncertain	  until	  2002	  owing	  to	  conflicting	  literature	  data.	  The	   plant	   lignan,	   7’-­‐hydroxylignano-­‐9,9’-­‐lactone	   parabenzlactone	   (–)-­‐29a	  was	   isolated	   for	   the	   first	   time	   in	   1970.64	   In	   1976	   its	   stereochemistry	   was	  assigned	   (erroneously)	   as	   (7’R),65	   because	   the	   deduction	   was	   based	   on	   the	  absolute	   configurations	   of	   podorhizol	   (7S)-­‐28a	   and	   its	   epimer	   epipodorhizol	  (7R)-­‐28b,	  determined	  by	  Kuhn	  and	  Wartburg.63	  The	  1H-­‐NMR	  parameters	  of	  H-­‐7	  (δ	  and	  J)	  of	  podorhizol	  (7S)-­‐28a	  and	  epipodorhizol	  (7R)-­‐28b	  were	  applied65,66	  to	  show	  that	  (–)-­‐parabenzlactone	  possess	  the	  (7’R)	  configuration.	  Obviously	  the	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3.3 Dietary lignans Due	  to	   their	  ubiquitous	  presence,	   lignans	  are	   included	   in	  our	  daily	  diet.	  Being	  fiber-­‐related	  polyphenols,105	  they	  are	  present	  at	  considerable	  concentrations	  in	  fiber-­‐rich	   foods,	   such	   as	  whole	   grain	   products,	   cereals	   and	   seeds,	   but	   also	   in	  fruits,	   berries,	   vegetables,	   and	   legumes.	   However,	   the	   highest	   lignan	  concentrations	   have	   been	   found	   in	   oilseeds	   such	   as	   flaxseed,106	   linseed	   and	  sesame	  seed.107	  At	  the	  ecological	  level	  lignans,	  having	  antimicrobial,	  antifungal,	  insecticidal	   and	   antioxidant	   properties	   among	   others,	  may	   have	   a	   role	   in	   the	  plant	  defence.	   Lignans	  have	   also	   various	  biological	   effects,	   e.g.	   anticancer	   and	  antiviral	   effects,	   and	   influence	   on	   gene	   expression	   (activation).108,109,110	  Originally	   only	   secoisolariciresinol	  18	   and	  matairesinol	  17	  were	   identified	   as	  precursors	   of	   the	  mammalian	   lignans	   enterolactone	  52	   and	   enterodiol	  53.111	  Later	   several	   other	   precursors	   were	   found,	   such	   as	   pinoresinol	   22,	  syringaresinol	   60,	   lariciresinol	   23,	   arctigenin	   61	   and	   7’-­‐hydroxymatairesinol	  
31.81,98,107	  Already	   in	   the	  early	  1980’s	   it	  was	  suggested	  that	  a	  diet	  rich	   in	   lignans	  and	  other	  phytoestrogens	  may	  protect	  against	  a	  range	  of	  chronic	  western	  diseases,	  such	   as	   breast	   cancer	   and	   osteoporosis.	   The	   connection	   between	   diet	   and	  diseases	  was	  originally	  introduced,	  because	  in	  Asian	  countries,	  where	  soybean	  products	   are	   staple	   food,	   there	   was	   until	   recently	   a	   very	   low	   incidence	   of	  hormonal	  cancers	  and	  coronary	  heart	  disease.	  Nowadays,	  particularly	  in	  Japan	  the	   incidence	   is	   increasing	   due	   to	   a	   change	   in	   dietary	   habits,	   and	   the	   disease	  risk	  has	  also	  observed	  to	  increase	  after	  immigration	  from	  Asia	  to	  United	  States	  and	  going	  native	  in	  diet.	  Numerous	  studies	  have	  been	  conducted	  to	  evaluate	  the	  hypothesis,	   that	   consumption	  of	   fiber-­‐rich,	   low-­‐fat	   diet	   is	   linked	  with	   a	   lower	  risk	   of	   breast	   cancer	   and	   other	   estrogen-­‐related	   diseases.112,113.	   It	   has	   been	  suggested	  that	  this	  may	  be	  related	  with	  the	  high	  intake	  of	  fiber-­‐associated	  plant	  lignans	   that	   are	   converted	   to	  mammalian	   lignan	   enterolactone	  52.	   In	   several	  case-­‐control	  epidemiological	  studies,	  an	  inverse	  correlation	  between	  serum	  and	  urine	   enterolactone	   concentrations	   and	   breast	   cancer	   risk	   has	   been	   found,	  while	   in	   some	   studies	   no	   correlation	  was	   found.	   In	  most	   of	   the	   recent	   cohort	  studies,	   the	   correlation	   between	   enterolactone	   and	   breast	   cancer	   risk	   has	  remained	   unclear.100,112,114,115	   However,	   in	   recent	   meta-­‐analyses,	   combining	  results	  of	   several	   cohort	  and	  case-­‐control	   studies,	  plant	   lignans	  have	  shown	  a	  possible	   association	   with	   reduced	   breast	   cancer	   risk	   in	   postmenopausal	  women.116,117	  To	   estimate	   lignan	   intake	   in	   various	   populations	   and	   demonstrate	   the	  association	  between	  the	   lignan	  containing	  food	  and	  risk	  of	  developing	  chronic	  diseases,	   lignan	   contents	   of	   foods	   in	   different	   countries	   have	  been	  quantified.	  106,118,119,120	  Previously	  whole	  grains	  were	  considered	  the	  most	  important	  lignan	  sources.	   When	   more	   dietary	   lignans	   are	   included	   in	   these	   databases,	   it	   has	  become	  clear	  that	  some	  vegetables	  and	  fruits	  are	  as	  important	  lignan	  sources	  as	  whole	   grains.	   However,	   in	   countries	   like	   Finland,	   rye	   bread	   contributes	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significantly	   to	   the	   intake	   of	   lignans	   because	   of	   its	   relatively	   high	  consumption.120	  The	   reported	   lignan	   compositions	   and	   concentrations	   in	   different	   studies	  are	   greatly	   dependent	   on	   the	   sample	   pre-­‐treatment	   applied	   and	   on	   the	  analytical	  method	  used,	   and	   variations	   are	   observable	   even	  when	  using	   same	  sample	   preparation	   and	   analytical	   methods.121	   Thus	   it	   is	   possible	   that	   the	  content	  of	   lignans	  and	  the	  conjugation	  patterns	  of	   individual	   lignans	  may	  vary	  within	  the	  same	  species	  depending	  on	  natural	  variation,	  such	  as	  genetic	  factors	  or	  growth	  conditions.81,107	  It	  also	  seems	  that	  as	  the	  research	  is	  increasing,	  new	  different	  precursors	  are	  continuously	  found.	  In	  many	  studies	  only	  a	  few	  lignans	  have	   been	   determined,	   probably	   due	   to	   a	   lack	   of	   standards.	   Previously	   only	  matairesinol	   17	   and	   secoisolariciresinol	   18	   were	   quantified,	   and	   they	   were	  considered	   the	   major	   lignans	   in	   rye,122	   but	   later	   pinoresinol	   22,98	   and	  syringaresinol	   60123	   were	   found	   to	   be	   the	   more	   abundant	   precursors.	   Some	  lignans	   are	   acid	   labile,	   and	   others	   are	   of	   limited	   stability	   under	   alkaline	  conditions.	  Different	  conjugated	   forms	  require	  different	  hydrolysis	  conditions.	  Hence,	  the	  establishment	  of	  one	  universally	  applicable	  method	  for	  analysis	  of	  a	  broad	  spectrum	  of	  lignans	  in	  various	  matrices	  is	  likely	  too	  demanding,	  and	  it	  is	  necessary	  to	  employ	  complementary	  sample	  preparation	  methods.121	  Natural	  variations,	  identity	  of	  lignan	  glycosides,	  enantiomeric	  compositions	  and	  oligomeric	  or	  polymeric	  derivatives	  of	  lignans	  have	  been	  studied	  to	  a	  very	  limited	   degree.107	   It	   is	   known	   that	   even	   a	   small	   difference	   in	   a	   plant	   lignan	  structure	   results	   in	  marked	   changes	   in	   biological	   acivity	   in	   vivo	   as	  well	   as	   in	  lignan	  metabolism.124,125	  Thus	  the	  study	  is	  just	  beginning.	  
3.4 Metabolism of dietary lignans The	   metabolism	   of	   dietary	   lignans	   is	   under	   continuous	   investigation.	   The	  mammalian	   lignans	   are	   formed	   from	  plant	   lignans	   and	   their	   glycosides	   in	   the	  human	  body	   in	   the	   gastrointestinal	   tract.	   The	   bacteria	   hydrolyse	   the	   possible	  sugar	  moiety	  of	  the	  plant	  lignan	  glycosides	  to	  release	  the	  plant	  lignan.	  The	  more	  hydrophilic	   lignan	   precursors	   (such	   as	   secoisolariciresinol	   diglucoside)	   are	  readily	   metabolised	   to	   enterodiol	   53	   and	   enterolactone	   52	   by	   the	   intestinal	  microbiota	  before	  absorption,	  while	  some	  other	   lignans	  (such	  as	  sesamin)	  are	  absorbed	   and	   metabolised	   in	   the	   liver,	   excreted	   in	   bile	   and	   undergo	  enterohepatic	  circulation,	  and	  then	  further	  metabolised	  to	  mammalian	   lignans	  by	   the	   intestinal	   microflora.99	   The	   path	   from	   secoisolariciresinol	   18	   and	  matairesinol	  17	  to	  enterolactone	  is	  well	  elucidated,	  but	  overall	  there	  are	  many	  unsolved	  aspects	  in	  the	  complex	  phenomena	  in	  mammals.	  The	  biosynthesis	  of	  matairesinol	  17	  and	  secoisolariciresinol	  18	  in	  plants	  has	  been	   reported	   to	   occur	   by	   the	   breakbown	   of	   pinoresinol	   22	   to	  secoisolariciresinol	   via	   lariciresinol	  23.	   The	   intestinal	   bacterial	  metabolism	  of	  pinoresinol	  seems	  to	  occur	  in	  a	  similar	  way.	  The	  hydrolysis	  of	  lignan	  glycosides	  to	  their	  aglyconic	  forms	  is	  the	  first	  step	  (Scheme	  15).	  Second,	  the	  demethylation	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of	  a	  methoxy	  group	  adjacent	   to	  an	  aromatic	  hydroxy	  group	  takes	  place	  easily,	  while	  two	  vicinal	  methoxy	  groups	  are	  rather	  resistant	  to	  demethylation.	  Third,	  4-­‐OH-­‐dehydroxylation	   which	   takes	   place	   leaving	   the	   3-­‐hydroxy	   group	   on	   the	  phenyl	   ring.	   Such	   pattern,	   present	   in	   e.g.	   mammalian	   lignans,	   appears	   to	   be	  stable	   and	   resistant	   to	   further	   dehydroxylations.	   The	   oxidation	   of	  dibenzylbutanediols	  to	  dibenzylbutanelactone	  may	  occur	  at	  each	  step.98,126,127	  Most	  of	  the	  lignans	  are	  chiral	  due	  to	  their	  chemical	  structure,	  and	  possess	  at	  least	   one	   pair	   of	   enantiomers.	   The	   dietary	   lignans	   occur	   in	   different	  stereochemical	   forms.107	   So	   do	   the	  mammalian	   lignans	   enterolactone	  52	   and	  enterodiol	   53,	   having	   two	   enantiomeric,	   mirroring	   forms	   (8R,8’R)-­‐(–)	   and	  (8S,8’S)-­‐(+).	  The	  absolute	  configurations	  at	  the	  chiral	  carbons	  8	  and	  8’	  seem	  not	  to	   change	  during	   the	   various	   reactions	  performed	  by	   intestinal	   bacteria.127,128	  However,	   the	   first	   found	   mammalian	   lignans	   were	   racemic,1,129	   which	   might	  indicate	   that	   the	   net	   formation	   of	   both	   enantiomeric	   forms	   of	   mammalian	  lignans	  is	  close	  to	  a	  racemic	  mixture.	  Different	  studies	  have	  analysed	  the	  human	  intake	  of	  lignans,	  but	  so	  far	  it	   is	  unknown	  what	   proportion	   of	   the	   ingested	  plant	   lignans	   is	  metabolised	   in	   the	  gut,	  and	  absorbed	   finally	  reaching	  the	  target	   issue.99	  The	  serum	  enterolactone	  concentration	   varies	  widely	   in	   the	   population,	   and	   the	   consumption	   of	   lignan	  containing	  foods	  explains	  only	  a	  small	  part	  of	  the	  variation.130	  Inter-­‐individual	  differences	   in	   cell	   densities	   of	   mammalian	   lignan	   producing	   bacteria	   may	  explain	   the	   differences	   in	   blood	   concentrations	   of	   enterolignans.99	   Use	   of	  antibiotics	   lowers	   the	   serum	   enterolactone	   concentrations,131	   which	   support	  the	   suggestion	   of	   a	   crucial	   role	   for	   the	   gut	   in	   the	   metabolism	   of	   lignans.132	  However,	   there	   are	   several	   variables	   complicating	   the	   study	   and	   to	   be	   taken	  into	   account:	   gender,	   age,	   body	   mass	   index,	   diet,	   nutrition	   (when	   used	  questionnaires,	  people	  may	  overestimate	   their	  consumption	  of	  vegetables	  and	  other	  healthy	  foods),	  use	  of	  antibiotics,	  smoking,	  etc.	  may	  affect.133	  In	  addition	  to	  the	  most	  studied	  enterolactone	  and	  enterodiol,	  there	  might	  be	  other	  relevant	  metabolites,	  and	  also	  the	  plant	  lignans	  may	  have	  health	  benefiting	  properties	  as	  such.96,134,135,136	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4 Stable isotope labelling and lignans 
Lignans	   may	   be	   labelled	   with	   isotopes	   of	   carbon,	   oxygen	   and	   hydrogen	  depending	   on	   their	   elemental	   composition.	   In	   this	   section	   the	   labelling	   of	  lignans	  with	  deuterium,	  the	  stable,	  heavy	  isotope	  of	  hydrogen	  is	  reviewed.	  Also	  the	  syntheses	  of	  stable	  carbon-­‐13	  and	  oxygen-­‐18	  labelled	  lignan	  analoques	  are	  briefly	   discussed.	   Radioactive	   tritium	   and	   carbon-­‐14	   labellings	   are	   excluded	  from	  this	  thesis.	  
4.1 Stable isotope labelled compounds The	   interest	   in	   stable	   isotope	   labelled	   compounds	   has	   resulted	   from	   the	  numerous	   application	   of	   mass	   spectrometry	   as	   a	   specific	   detection	   tool	   in	  biomedical,	   pharmacological,	   and	   environmental	   analysis.	   In	   addition	   to	  metabolic89,124,137	  and	  analytical	  studies,138,139,140	  isotopically	  labelled	  analogues	  are	   required	   also	   for	   reaction	   mechanistic	   studies141	   and	   structural	  elucidation.142	  The	   advances	   in	   the	   knowledge	   of	   the	   absorption	   and	   the	   metabolism	   of	  lignans	   and	   other	   dietary	   phenols	   have	   been	   associated	   especially	   with	   the	  development	  of	  sophisticated	   liquid	  chromatography–mass	  spectrometry	  (LC–MS)	   techniques.	  However,	   the	  phytoestrogen	  contents	  are	  usually	  very	   low	   in	  the	  biological	  matrices,	  and	  these	  techniques	  remain	   largely	  qualitative	  unless	  authentic	   standards	   are	   available.	   Thus,	   isotopically	   and	   isomerically	   pure	  polydeuterated	  lignans	  and	  other	  phytoestrogens	  are	  needed	  as	  references	  for	  quantitation	   of	   these	   compounds	   in	   biological	   samples.	   The	   use	   of	   structural	  analogues	   as	   internal	   standards,	   rather	   than	   authentic	   isotope	   labelled	  isotopologues,†	   is	   undesirable	   because	   they	   will	   have	   different	   behavior	   in	  sample	   preparation	   as	   well	   as	   different	   retention	   times	   and	   ionization	  properties	   compared	   with	   the	   analytes.	   An	   authentic	   stable	   isotope	   labelled	  analogue	   of	   a	   compound	   is	   identical	   to	   the	   compound	   of	   interest	   except	   for	  mass.	  The	  most	  common	  techniques	   for	   the	  determination	  of	   lignan	  contents	  are	  liquid	   chromatography	   (LC)	   and	   gas	   chromatography	   (GC)	   with	   various	  detection	   systems.	   By	   far	   the	   predominant	   and	  most	   popular	   applications	   for	  analysing	   lignans	   and	   other	   phytoestrogens	   are	   the	   (HP)LC–MS	   methods.	   In	  contrast	  to	  GC–MS,	  LC–MS	  has	  the	  advantage	  that	  it	  is	  not	  necessary	  to	  prepare	  volatile	   derivatives	   and	   that	   conjugated	   forms,	   such	   as	   the	   glycosides,	   can	   be	  analysed	  as	  easily.121,143,144	  One	  of	  the	  most	  reliable	  and	  sensitive	  method	  of	  quantification	  is	  based	  on	  the	  addition	  of	  a	  stable	  isotope	  analogue	  of	  the	  analyte	  of	  interest	  into	  a	  sample	  
                                                †	  Isotopologues	  are	  substances	  that	  differ	  only	  in	  isotopic	  composition,	  e.g.	  CH3OH,	  CD3OH,	  CH2DOH.	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at	   a	   known	   concentration.	   The	   technique	   is	   called	   stable	   isotope	   dilution	  (SID).145	   Since	   the	   analyte	   and	   its	   isotopologue	   possess	   almost	   identical	  chemical	  and	  physical	  properties,‡,146	   the	   isotopic	  ratio	  remains	  stable	  as	   they	  are	   affected	   equally	   by	   variations	   at	   extraction,	   sample	   preparation,	   injection	  and	   instrument	   parameters.147	   In	   the	   ion	   chromatogram,	   the	   analyte	   and	   its	  labelled	   analogue	   usually	   have	   the	   same	   retention	   time.	   Thus,	   all	   the	   losses	  during	   sample	   preparation	   can	   be	   corrected	   for	   and	   the	   analytes	   reliably	  identified	  and	  quantified.	  
4.1.1 Requirements for the internal standards In	  quantitation	  methods,	  internal	  standards	  are	  used	  to	  take	  into	  account	  all	  the	  losses	   during	   the	   process	   and	   the	   behaviour	   of	   the	   compounds	   during	   the	  measurement.	   A	   stable,	   chemically,	   isomerically	   and	   isotopically	   pure	  isotopologue	   of	   the	   analyte	   is	   an	   optimal	   standard.	   As	   the	   physicochemical	  properties	  of	  an	  isotope	  labelled	  analogue	  are	  practically	  identical	  with	  those	  of	  the	   analyte,	   no	   separation	   takes	   place	   during	   the	   process:	   the	   analyte	   and	   its	  labelled	   analogue	   have	   the	   same	   retention	   times	   in	   chromatography	   but	  different	  m/z	  value	  in	  mass	  spectometry.	  Labelled	   compounds	   that	   are	   used	   as	   internal	   standards	   in	   quantitative	  analytical	   techniques	   such	  as	  GC–MS	  and	  LC–MS	  must	   fulfil	   certain	   important	  criteria.	   First,	   the	   compounds	   and	   the	   labels	   must	   remain	   stable	   during	   the	  entire	  sample	  preparation	  procedure	  and	  analysis.	  Second,	  there	  can	  not	  be	  any	  unlabelled	  species	  present	  in	  the	  standard.	  And	  third,	  the	  labelled	  analogue	  and	  the	  analyte	  should	  have	  a	  difference	  of	  at	  least	  three	  units	  in	  the	  M+	  m/z	  value	  in	  order	  to	  avoid	  the	  internal	  standard	  peaks	  overlapping	  those	  of	  the	  analytes.148	  On	  the	  other	  hand,	  it	  is	  claimed	  that	  for	  internal	  standards	  an	  optimal	  number	  of	   deuteriums	   would	   be	   from	   three	   to	   five,	   and	   more	   deuteriums	   in	   the	  molecule	   may	   cause	   chromatographic	   separation	   between	   internal	   standard	  and	  the	  analyte.149,150	  However,	  no	  chromatographic	  separation	  of	  a	  deuterated	  compound	  from	  the	  corresponding	  unlabelled	  compound	  has	  been	  reported	  for	  lignans.	  
                                                ‡	   Isotopes	   do	   differ.	   Due	   to	   the	   different	  masses,	   deuterium	   and	   hydrogen	   (other	   isotopes	   as	  well)	  have	   different	   zero-­‐point	   energies.	   The	   zero-­‐point	   energy	   differences	   produce	   so	   called	   isotope	   effects:	  steric	  effect	  (the	  C–D	  bond	  length	  is	  shorter	  than	  the	  C–H	  bond	  length);	  inductive	  effect	  (the	  C–D	  bond	  is	  more	   polar	   than	   the	   C–H	   bond);	   hyperconjugative	   effect	   (the	   C–D	   bond	   is	   less	   polarisable	   than	   C–H	  bond),151,160	  and	  kinetic	   isotope	  effect.	  C–D	  bond	   is	  marginally	  stronger	   than	  C–H	  bond,	  and	  reactions	   in	  which	  C–H	  bonds	  break	  may	  go	   (in	   theory	  at	   room	  temperature	  7	   times)	   faster	   than	  reactions	   in	  which	  	  C–D	  bonds	  break,	  if	  the	  bond	  to	  H	  (or	  D)	  is	  involved	  in	  the	  rate-­‐determing	  step.	  Thus	   isotopes	   have	   different	   physical	   properties,	   e.g.	   on	   their	   nuclear	   spin,	  which	   affects	   how	   they	  behave	   in	   NMR.	   Since	   IR	   stretching	   frequencies	   depend	   on	   mass,	   C–D	   bonds	   have	   lower	   stretching	  frequencies	  than	  C–H	  bonds.	  And	  as	  some	  chemical	  properties	  depend	  on	  atomic	  mass,	  isotopes	  may	  also	  differ	  chemically.	  The	  difference	   is	  considered	  more	  or	   less	  significant	  only	   for	  hydrogen,	  since	  no	  other	  element	  has	  one	  isotope	  twice	  as	  big	  as	  another.146	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Isotopic	   purity	   is	   an	   important	   feature	   of	   an	   isotope	   labelled	   compound.	  However,	   in	   the	   literature	   and	   in	   the	   catalogs	   of	   commercial	   suppliers	   there	  seems	   not	   to	   be	   any	   established	   practice	   on	   how	   to	   define	   or	   measure	   the	  isotopic	  purity,	  isotope	  distribution	  or	  isotope	  content.	  In	  this	  thesis	  and	  in	  the	  current	  work,	   the	   isotope	  distribution	   is	  determined	  by	  NMR	  and	   the	   isotopic	  purity	   is	   indicated	   as	   the	   percentage	   of	   the	   most	   abundant	   d-­‐species,	  determined	   from	   the	  molecular	   ion	   region	   in	   EI	  mass	   spectra	   by	   comparison	  with	  those	  of	  the	  undeuterated	  compounds	  (as	  will	  be	  discussed	  in	  more	  detail	  in	  Chapter	  6.2.4).	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5 The aims of the present study 
Our	  interest	  in	  lignans	  originated	  from	  the	  possible	  biological	  effects	  and	  health	  benefits	   of	   these	   compounds,	   and	   the	   work	   is	   part	   of	   an	   interdisciplinary	  research	   project	   entitled	   Lignans,	   Phytoestrogens	   and	   Human	   Health.	   As	  discussed	   in	   the	   previous	   sections,	   analytical	   and	   metabolic	   studies	   require	  deuterium	   labelled	   standards.	   Particularly,	   isomerically	   and	   isotopically	   pure	  stable	   polydeuterated	   lignans	   are	   needed	   in	   the	   development	   of	   quantitative	  analysis.	  To	  meet	  the	  overall	  goals,	  the	  aim	  of	  the	  present	  work	  was	  to	  examine	  the	  deuteration	  of	  lignans,	  i.e.	  how	  and	  in	  which	  order	  the	  H/D	  exchange	  occurs	  in	  a	   lignan	   framework,	  and	  what	   is	   the	  degree	  of	   the	  deuteration	  (i.e.	   isotopic	  purity).	   The	   experimental	   observations	   were	   compared	   to	   the	   results	   of	  computational	   studies	   (ESP	   charges	   or	  molecular	  modelling),	   and	   the	   further	  understanding	   on	   the	   deuteration	   reaction	  was	   utilised	   in	   synthesising	   stable	  and	   isotopically	   pure	   deuterium	   labelled	   lignans.	   Thus	   new,	   stable	   and	  isotopically	   pure	   deuterium	   labelled	   lignano-­‐9,9’-­‐lactones	   (5)	   and	  	  9,9’-­‐epoxylignanes	   (6)	   were	   synthesised,	   suitable	   for	   analytical	   studies	   as	  reference	  compounds.	  Lignans	   have	   been	   recognised	   as	   interesting	   and	   challenging	   targets	   for	  organic	   synthesis	   due	   to	   their	   diverse	   structures	   as	   well	   as	   their	   important	  biological	   properties.	   Several	   synthetic	   approaches	   have	   been	   published	   over	  the	  years.	  The	   racemic	   syntheses	  are	   still	   under	   continuous	  development,	  but	  stereoselective	   syntheses	   are	   the	   predominant	   objective	   in	   this	   field,	   thus	  we	  also	   engaged	   in	   this	   challenge.	  While	   developing	   a	   general	   procedure	   for	   the	  stereoselective	   synthesis	   of	   7’-­‐hydroxylignano-­‐9,9’-­‐lactones,	   it	  was	   found	   that	  the	   stereoselective	   reduction	   of	   the	   7’	   keto	   group	  with	   L-­‐Selectride	   (Chapter	  2.4)	  afforded	  a	  rearranged	  byproduct.	  The	  unexpected	  byproduct	  led	  to	  further	  studies	   on	   the	   rearrangement	   reactions	   in	   basic	   conditions.	   Thus	   aims	   of	   the	  present	   work	   were	   to	   examine	   the	   mechanism	   of	   the	   rearrangement	   of	  	  7’-­‐hydroxylignano-­‐9,9’-­‐lactones	   in	   basic	   conditions	   and	   to	   study	   the	  stereochemistry	   of	   the	   rearranged	   products.	   The	   absolute	   configurations	   of	  three	  lignan	  regio-­‐	  and	  stereoisomers	  were	  proven	  by	  X-­‐ray	  spectroscopy,	  and	  some	  conflicting	  or	  erroneus	  data	  in	  literature	  were	  clarified.	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'
Figure 14 Optimised structures for the three different conformations of dehydroxycubebin 84: 
extended (on the left) and two $-stacked conformations. The stacked conformations 
are preferred under the deuteration reaction conditions, and the stacked structure in 
the middle is energetically slightly lower than the stacked conformation on the right, 
probably due to more favorable multipole interactions between the oxygen 
containing substituents. 
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Figure 15 The “up” and “down” proton addition illustrated in the dehydroxycubebin molecule. 
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reaction	  is	  reversed	  and	  the	  deuterium	  is	  liberated	  back	  to	  the	  solution.	  The	  2-­‐position	   differs	   slightly	   from	   the	   5-­‐position	   in	   being	   less	   restricted	   and	   is	  partially	  deuterated.	  Brassilignan	  83,	  whose	  methoxy	  groups	  are	  flexible	  and	  freely	  rotating,	  can	  accommodate	  the	  water	  molecules	  on	  the	  “down”	  face,	  and	  both	  reaction	  steps	  are	  possible.	  The	  computational	  structural	  analysis	  together	  with	  the	  deuteration	  results	  indicate	  that	  the	  aryl	  rings	  cannot	  rotate	  freely	  in	  either	  of	  the	  lignan	  molecules.	  Thus	  there	  are	  two	  atropisomers,	  i.e.	  the	  stacked	  conformers,	  and	  the	  molecules	  do	  not	  switch	  between	  them.	  It	  seems	  that	  there	  are	  two	  factors	  preventing	  the	  deuteration	  of	  being	  completed	   in	  positions	  2	  and	  5	   in	  dehydroxycubebin	  84:	  one	   conformation-­‐independent,	   probably	   quasiaromatic	   nature	   of	   the	   five-­‐membered	   methylenedioxy	   substituent	   ring,	   that	   restricts	   the	   complete	  deuteration	   at	   ortho-­‐positions.	   The	   other	   effect	   is	   steric,	   conformation	  dependent,	  and	  blocks	  even	  the	  partial	  deuteration	  at	  the	  C-­‐5	  (and	  C-­‐5’)	  of	  84.	  
6.2.4 Characterisation of the deuterated compounds The	   deuterated	   compounds	   were	   characterised	   by	   NMR	   and	   MS	   and	   by	  comparison	  of	   the	  spectra	  with	   those	  of	  undeuterated	  analogues.	  The	  number	  of	  deuterium	  atoms	  in	  a	  product	  as	  well	  as	  the	  isotopic	  purity	  was	  determined	  by	  MS	  (EI	  or	  ESI).	  The	  locations	  of	  the	  deuterium	  atoms	  were	  established	  from	  1H-­‐	  and	  13C-­‐NMR	  studies.	  The	   isotopic	   purities	   of	   deuterated	   lignans	   in	   this	   study	  were	   determined	  from	  the	  ion	  clusters	  in	  the	  molecular	  ion	  region	  in	  the	  EI	  or	  ESI	  mass	  spectra	  by	   comparison	   with	   those	   of	   undeuterated	   compounds.	   For	   the	   native	  butyrolactone	  and	  tetrahydrofuran	  type	  lignans	  the	  M–1	  and	  M–2	  peaks	  usually	  are	   very	   small	   (2–5	  %	   of	   the	   intensity	   of	   the	   molecular	   ion	   peak)	   or	   totally	  absent	  (Figure	  16).	  
	  
Figure 16 The molecular ion region of unlabelled 77 (M = 358) and stable deuterium labelled 
analog d3-77 (M = 361). 
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6.2.5 H/D exchange reactions for lignans The	  results	   in	  deuterating	   lignans,	   in	   terms	  of	   isotopic	  purity,	  are	  rather	  good	  regardless	   of	   the	   acidic	   deuteration	   reagent	   used.	   The	   first	   H/D	   exchange	  reaction	  was	  done	  for	  enterolactone	  52	  with	  refluxing	  DBr	  in	  D2O	  (Scheme	  21,	  p.	  43),	  which	  gave	  relatively	  poor	  yield,	  only	  35	  %,	  although	  the	  isotopic	  purity	  was	  over	  90	  %.	  Probably	  the	  lignan	  molecule	  did	  not	  fully	  survive	  the	  refluxing	  conditions,	  and	  since	  then	  good	  yields	  and	  isotopic	  purities	  have	  been	  achieved	  at	  lower	  temperatures.	  Comparing	   the	   reaction	   times	   (Table	   1),	   it	   seems	   that	   long	   reaction	   times	  result	   from	   solubility	   issues:	   using	   any	   dissolving	   help,	   such	   as	   THF/CDCl3	  (entry	   3)	   or	   an	   ionic	   liquid	   [bmim]Cl	   (entry	   5),	   shortens	   the	   reaction	   times	  significantly.	   Although	   some	   lignans,	   e.g.	   matairesinol,	   were	   able	   to	   be	  deuterated	   in	  DCl/D2O	   in	  30	  minutes	  without	   the	  help	  of	   ionic	   liquid,	  most	  of	  them	  gained	  from	  presence	  of	  a	  co-­‐solvent.	  Attemps	  to	  deuterate	  enterolactone	  
52	   in	   DCl/D2O	   without	   a	   co-­‐solvent	   resulted	   a	   ca	   1:1	   mixture	   of	   unchanged	  starting	   material	   d0-­‐52	   and	   hexadeuterated	   enterolactone	   d6-­‐52.	   When	  deuteroethanol	   (CH3CH2OD)	   was	   used	   as	   a	   co-­‐solvent,	   no	   unlabelled	   species	  were	  present,	  but	  reaching	  d6-­‐52	  in	  85	  %	  isotopic	  purity	  needed	  longer	  reaction	  times	  (4	  hours,	  entry	  6)	  than	  with	  ionic	  liquid	  [bmim]Cl	  (40	  min,	  entry	  5).	  
Table 1. Reaction conditions of known acidic H/D exchange reactions for lignans. 
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Figure 19 X-ray crystal structure of all-trans-86 (50 % probability ellipsoids). ORTEP plot.I 
6.3.3 Crystal structures of (–)-parabenzlactone and rearranged 
regioisomer. As	  mentioned	   in	   the	   Chapter	   2.4,	   the	   reduction	   of	   7’-­‐oxolignano-­‐9,9’-­‐lactones	  with	   L-­‐Selectride	   produced	   in	   most	   cases	   a	   byproduct	   identified	   as	   the	  rearranged	   lactone,	   in	   addition	   to	   the	   desired	   target	   (7’S)-­‐OH-­‐lignano-­‐9,9’-­‐lactone	  (Scheme	  4,	  p.	  20).	  Usually	  the	  rearranged	  lactone	  was	  only	  detected	  by	  NMR,	   but	   in	   the	   case	   of	   7’,8’-­‐trans-­‐8,8’-­‐cis-­‐33a,70	   7’,8’-­‐trans-­‐8,8’-­‐cis-­‐36d	   and	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐40b	  the	  products	  were	  isolated	  and	  characterised.I	  The	  7’,8’-­‐
trans-­‐8,8’-­‐cis	  stereochemistry	  was	  assigned	  by	  2D	  NMR	  (COSY	  and	  NOESY)	  and	  on	   the	   basis	   of	   the	   presumed	   mechanism	   of	   formation:	   the	   7’-­‐alkoxyborane,	  formed	   in	   the	   L-­‐Selectride	   reaction,	   attacks	   the	   lactone	   carbonyl	   producing	   a	  primary	  alcohol	  and	  translactonisation	  (Scheme	  6,	  p.	  22).	  As	  discussed	  before,	  in	  the	  literature	  there	  was	  only	  one	  lactone	  homochiral	  to	   ours,	   but	   with	   different	   aromatic	   substitution	   pattern,	  isohydroxymatairesinol	   7’,8’-­‐trans-­‐8,8’-­‐cis-­‐35a	   reported	   by	   Eklund	   et	   al.	  (Scheme	   5,	   p.	   21).76	   This	   lactone,	   obtained	   from	   a	   basic	   treatment	   of	   7’-­‐hydroxymatairesinol	  31	   is	   formed	   by	   a	   different	  mechanism	   than	   7’,8’-­‐trans-­‐8,8’-­‐cis-­‐33a,	   -­‐36d	   and	   -­‐40b,	   but	   they	  all	   have	  a	   clear	   correlation	  between	   the	  spectroscopic	   data,	   as	   can	   be	   seen	   in	   the	   Table	   A2	   in	   Appendix	   (p.	   97).	  Compound	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐33a	  was	  converted	  to	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐35a	  and	  the	  spectroscopic	  data	  were	   in	  agreement	  with	   those	  reported.76	  Additionally,	  we	   were	   able	   to	   crystallise	   7’,8’-­‐trans-­‐8,8’-­‐cis-­‐36d,	   and	   the	   absolute	  configuration	  of	  the	  rearranged	  product	  was	  confirmed	  also	  with	  X-­‐ray	  analysis	  (Figure	   20),	   as	   well	   as	   the	   (7’S)-­‐hydroxylignano-­‐9,9’-­‐lactone	  	  (–)-­‐parabenzlactone	  (7’S)-­‐29a	  (Figure	  21).II	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Figure 20 Rearranged lactone 7’,8’-trans-8,8’-cis-36d from L-Selectride reduction of 85. 
ORTEP plot (50 % probability ellipsoids).II 
	  
Figure 21 X-ray crystal structure of (–)-parabenzlactone (7’S)-29a. ORTEP plot (50 % 
probability ellipsoids).II 
6.3.4 Discussion on the all-trans and all-cis isomers of rearranged 
hydroxymatairesinol With	  the	  correct	  stereochemistry	  of	  all-­‐trans-­‐36c,65,I	  the	  1H	  NMR	  spectra	  of	  all-­‐
trans-­‐	  (entries	  1–5,	  Table	  2),	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐	  (entries	  6–9)	  and	  7’,8’-­‐cis-­‐8,8’-­‐
trans-­‐lignano-­‐9,7’-­‐lactones	   (entries	   10–14)	   show	   a	   close	   resemblance,	  particularly	  regarding	  the	  diagnostic	  peak	  of	  H-­‐7’.	   It	   is	   interesting	  to	  note	  that	  regardless	  of	  the	  alcohol	  being	  free	  or	  protected	  (TBDMS	  or	  Piv),	  there	  are	  no	  remarkable	  differences	  in	  the	  NMR	  spectra	  of	  the	  homochiral	  lignans.	  However,	  a	  similar	  comparison	  cannot	  be	  made	  in	  regard	  of	  all-­‐cis-­‐lignano-­‐9,7’-­‐lactones	  at	  the	  moment.	  There	  are	  only	  two	  all-­‐cis-­‐lignano-­‐9,7’-­‐lactones	  (entries	  15	  and	  16)	  reported	  to	  date	  presenting	  a	  significant	  difference	  for	  the	  H-­‐7’	  signals	  in	  both	  chemical	  shifts	  and	  coupling	  constants:	  δ	  5.12	  ppm,	  d,	  JH-­‐7’,H-­‐8’	  =	  9.3	  Hz	  for	  all-­‐cis-­‐








Deuteration	   of	   various	   lignano-­‐9,9’-­‐lactones	   and	   9,9’-­‐epoxylignanes	   was	  studied,	  and	  eleven	  new	  stable	  deuterium	  labelled	  lignans	  with	  good	  yields	  and	  high	   isotopic	   purity	   were	   synthesised.	   The	   method	   using	   D3PO4·BF3/D2O	   as	  deuteration	  reagent	  was	  used	  to	  examine	  the	  relative	  ease	  of	  H/D	  exchange	  at	  various	   aromatic	   positions,	   and	   the	   observed	   results	   were	   compared	   with	  calculated	   reactivities.	   When	   deuterating	   with	   DCl	   in	   D2O,	   the	   lignan	  dehydroxycubebin	  84	  gave	  unexpected	  results,	  and	  computational	  studies	  were	  performed	   to	   understand	   the	   deviating	   behavior	   from	   other	   close	   lignan	  analogues.	  The	   development	   of	   effective	   and	   fast	   deuteration	   methods	   is	   highly	  important	   since	   the	   availability	   of	   labelled	   compounds	   is	   usually	   the	   limiting	  factor	   in	   the	   development	   and	   use	   of	   quantitative	   methods.	   The	   results	   in	  deuterating	   lignans,	   in	   terms	   of	   isotopic	   purity,	   are	   rather	   good	   regardless	   of	  the	  acidic	  deuteration	  reagent	  used.	  However,	  the	  reaction	  times	  are	  often	  quite	  long,	  probably	  resulting	  from	  solubility	  issues,	  but	  the	  method	  using	  DCl	  in	  D2O	  and	  an	  ionic	  liquid	  as	  co-­‐solvent	  reduced	  the	  reaction	  times	  significantly.	  In	   our	   laboratory,	   while	   developing	   and	   optimising	   a	   stereoselective	  protocol	   to	   synthesise	   (7’S)-­‐hydroxylignano-­‐9,9’-­‐lactones,	   an	   unexpected	  rearranged	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐9,7’-­‐lactone	  was	  obtained	  as	  a	  byproduct,	  formed	  via	  translactonisation	  mechanism.	  The	  absolute	  configuration	  of	  the	  rearranged	  products	   as	  well	   as	   the	   7’-­‐hydroxylignano-­‐9,9’-­‐lactones	  were	   confirmed	  by	  X-­‐ray	   crystallography	   of	   36d	   and	   (–)-­‐parabenzlactone	   (7’S)-­‐29a.	   Similar	  	  9,7’-­‐lactones,	   but	   with	   different	   stereochemistry	   and	   different	   formation	  mechanism,	  were	  reported	  in	  the	  literature.	  Thus	  the	  rearrangement	  reactions	  of	   various	   hydroxylignano-­‐9,9’-­‐lactones	   and	   9,7’-­‐lactones	   were	   investigated.	  Mechanistic	   studies	   with	   18O	   labelled	   substrates	   supported	   the	   proposed	  translactonisation	   and	   p-­‐quinone	   methide	   mechanisms	   in	   the	   formation	   of	  	  7’,8’-­‐trans-­‐8,8’-­‐cis-­‐lignano-­‐9,7’-­‐lactones,	   but	   showed	   that	   both	   the	   presumed	  mechanism	   and	   the	   stereochemistry	   of	   the	   rearranged	   lactone	   obtained	   by	  treating	  (7’S)-­‐acetylparabenzlactone	  with	  2	  %	  KOH/MeOH	  were	  erroneous.	  The	  rearranged	  compound	  36c	  with	  an	  all-­‐trans-­‐stereochemistry	  was	  derived	  from	  a	  translactonisation	  with	  α-­‐epimerisation,	  driven	  by	  a	  relief	  of	  steric	  constrains	  in	   the	   rearranging	   lactone.	   The	   absolute	   configuration	   of	   the	   rearranged	  product	  36c	  was	  confirmed	  by	  X-­‐ray	  analysis	  of	   its	  dinitrobenzoate	  derivative	  all-­‐trans-­‐86.	   The	   crystal	   structures	   for	   (7’S,8R,8’R)-­‐7’-­‐hydroxylignano-­‐9,9’-­‐lactones,	   and	   9’-­‐hydroxylignano-­‐9,7’-­‐lactones	   possessing	   stereochemistry	  (7’S,8R,8’R)	  and	  (7’S,8S,8’R)	  are	   the	   first	  reported	   for	   these	  kind	  of	  structures,	  probably	   due	   to	   the	   amorphous-­‐like	   texture	   of	   lignans,	   which	   makes	   them	  demanding	  to	  crystallise.	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8 Experimental 
The	   general	   procedure	   for	   the	   synthesis	   of	   9,9’-­‐epoxylignanes	   from	  corresponding	   lignane-­‐9,9’-­‐diols	  was	   described	   in	   article	   V.	   Here	   the	   spectral	  data	  of	  the	  synthesised	  9,9’-­‐epoxylignanes	  is	  reported.	  The	  described	  conversion	  from	  lignane-­‐9,9’-­‐diol	  to	  a	  tetrahydrofuran	  lignan	  with	  conc.	  HCl	  under	  microwave	  heating	  is	  in	  most	  cases	  completed	  in	  less	  than	  30	  minutes,	  which	  makes	  it	  a	  fast	  and	  easy	  cyclisation	  method,	  compared	  with	  conventional	  heating	  methods.	  In	  most	  of	  the	  reviewedV	  conventional	  methods	  (e.g.	   refluxing	  with	  methanolic	  HCl,	  or	  stirring	  with	  p-­‐toluenesulfonyl	  chloride	  in	   pyridine)	   the	   cyclisation	   of	   dibenzyl-­‐1,4-­‐butanediols	   to	   3,4-­‐dibenzyl-­‐tetrahydrofurans	  takes	  several	  hours.	  Additionally,	  we	  have	  anticipated	  that	  our	  cyclisation	  method	  can	  work	  well	  also	  for	  synthesising	  the	  furofuran	  structures	  from	  tetraols.	  	  9,9’-­‐epoxylignane	  (8R*,8’R*-­‐6)	  	  1H-­‐NMR	  (300	  MHz,	  CDCl3)	  δ	  2.17–2.29	  (2H,	  m,	  H-­‐8,	  8’),	  2.57	  (2H,	  dd,	  J	  =	  8.4,	  13.8,	  H-­‐7a,	  7’a),	  2.70	  (2H,	  dd,	  J	  =	  5.7,	  13.8,	  H-­‐7b,	  7’b),	  3.52	  (2H,	  dd,	  J	  =	  6.6,	  8.7,	  	  H-­‐9a,	  9’a),	  3.89	  (2H,	  dd,	  J	  =	  6.6,	  8.7,	  H-­‐9b,	  9’b),	  7.08–7.29	  (10H,	  m,	  Ar-­‐H).	  13C-­‐NMR	  (75	  MHz,	  CDCl3)	  δ	  39.6	  (C-­‐7,	  7’),	  46.8	  (C-­‐8,	  8’),	  73.6	  (C-­‐9,	  9’),	  126.4	  (C4,	  4’),	  128.7	  (C-­‐2,	  2’,	  6,	  6’),	  128.9	  (C-­‐3,	  3’,	  5,	  5’),	  140.6	  (C-­‐1,	  1’).	  EIMS	  (70	  eV)	  m/z:	  M+	  252	  (15	  %),	  234	  (15),	  161	  (3),	  143	  (18),	  92	  (100),	  91	  (65).	  HRMS	  (EI):	  m/z	  calc.	  for	  C18H20O	  (M+)	  252.1514,	  found	  252.1505.	  	  Anhydrosecoisolariciresinol	  (8R*,8’R*-­‐24)	  4,4’-­‐dihydroxy-­‐3,3’-­‐dimethoxy-­‐9,9’-­‐epoxylignane	  1H-­‐NMR	   (300	  MHz,	  d6-­‐acetone)	  δ	   2.12–2.24	   (2H,	  m,	  H-­‐8,	   8’),	   2.49	   (2H,	   dd,	  	  
J	  =	  8.4,	  13.5,	  H-­‐7a,	  7’a),	  2.60	  (2H,	  dd,	  J	  =	  6.3,	  13.5,	  H-­‐7b,	  7’b),	  3.43	  (2H,	  dd,	  J	  =	  6.3,	  8.7,	  H-­‐9a,	  9’a),	  3.81	  (6H,	  s,	  3-­‐,	  3’-­‐OMe),	  3.81	  (2H,	  dd,	  J	  =	  6.6,	  15.3,	  H-­‐9b,	  9’b),	  6.61	  (2H,	  dd,	  J	  =	  1.8,	  8.1,	  H-­‐6,	  6’),	  6.73	  (2H,	  d,	  J	  =	  8.1,	  H-­‐5,	  5’),	  6.73	  (2H,	  d,	  J	  =	  1.8,	  H-­‐2,	  2’).	  13C-­‐NMR	   (75	   MHz,	   d6-­‐acetone)	   δ	   39.6	   (C-­‐7,	   7’),	   47.7	   (C-­‐8,	   8’),	   56.2	   (3-­‐,3’-­‐OMe),	  73.8	  (C-­‐9,	  9’),	  113.1	  (C-­‐2,	  2’),	  115.6	  (C-­‐5,	  5’),	  122.0	  (C-­‐6,	  6’),	  133.1	  (C-­‐1,	  1’),	  145.7	  (C-­‐4,	  4’),	  148.2	  (C-­‐3,	  3’).	  EIMS	  (70	  eV)	  m/z:	  M+	  344	  (59	  %),	  314	  (8),	  207	  (6),	  138	  (77),	  137	  (100),	  123	  (12),	   122	   (13),	   106	   (14).	   HRMS	   (EI):	   m/z	   calc.	   for	   C20H24O5	   (M+)	   344.4016,	  found	  344.1629.	  	  Enterofuran	  (8R*,8’R*-­‐54)	  3,3’-­‐dihydroxy-­‐9,9’-­‐epoxylignane	  1H-­‐NMR	   (500	  MHz,	  d6-­‐acetone)	  δ	   2.16–2.23	   (2H,	  m,	  H-­‐8,	   8’),	   2.50	   (2H,	   dd,	  	  
J	  =	  9.0,	  13.5,	  H-­‐7a,	  7’a),	  2.67	  (2H,	  dd,	  J	  =	  5.5,	  13.5,	  H-­‐7b,	  7’b),	  3.43	  (2H,	  dd,	  J	  =	  6.8,	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8.5,	  H-­‐9a,	  9’a),	  3.79	  (2H,	  dd,	  J	  =	  6.8,	  8.5,	  H-­‐9b,	  9’b),	  6.64–6.68	  (6H,	  m,	  H-­‐2,	  4,	  6,	  2’,	  4’,	  6’),	  7.09	  (2H,	  t,	  J	  =	  7.8,	  H-­‐5,	  5’),	  8.15	  (2H,	  s,	  3-­‐OH,	  3’-­‐OH).	  13C-­‐NMR	  (75	  MHz,	  d6-­‐acetone)	  δ	  39.8	  (C-­‐7,	  7’),	  47.5	  (C-­‐8,	  8’),	  73.7	  (C-­‐9,	  9’),	  113.8	   (C-­‐4,	   4’),	   116.5	   (C-­‐2,	   2’),	   120.7	   (C-­‐6,	   6’),	   130.2	   (C-­‐5,	   5’),	   143.3	   (C-­‐1,	   1’),	  158.3	  (C-­‐3,	  3’).	  HRMS	  (EI):	  m/z	  calc.	  for	  C18H20O3	  (M+)	  284.1412,	  found	  284.1424.	  	  Brassilignan	  (8R*,8’R*-­‐83)	  3,3’,4,4’-­‐tetramethoxy-­‐9,9’-­‐epoxylignane	  1H-­‐NMR	  (300	  MHz,	  CDCl3)	  δ	  2.14–2.26	  (2H,	  m,	  H-­‐8,	  8’),	  2.53	  (2H,	  dd,	  J	  =	  8.1,	  13.8,	  H-­‐7a,	  7’a),	  2.64	  (2H,	  dd,	  J	  =	  6.0,	  13.8,	  H-­‐7b,	  7’b),	  3.53	  (2H,	  dd,	  J	  =	  6.0,	  9.0,	  	  H-­‐9a,	  9’a),	  3.84	  (6H,	  s,	  OCH3),	  3.85	  (6H,	  s,	  OCH3),	  3.91	  (2H,	  dd,	  J	  =	  6.6,	  8.7,	  H-­‐9b,	  9’b),	  6.59	  (2H,	  d,	  J	  =	  1.8,	  H-­‐2,	  2’),	  6.63	  (2H,	  dd,	  J	  =	  1.8,	  8.1,	  H-­‐6,	  6’),	  6.76	  (2H,	  d,	  	  
J	  =	  8.1,	  H-­‐5,	  5’).	  13C-­‐NMR	  (125	  MHz,	  CDCl3)	  δ	  39.1	  (C-­‐7,	  7’),	  46.6	  (C-­‐8,	  8’),	  55.8	  (OCH3),	  55.9	  (OCH3),	  73.3	  (C-­‐9,	  9’),	  111.2	  (C-­‐5,	  5’),	  112.0	  (C-­‐2,	  2’),	  120.6	  (C-­‐6,	  6’),	  133.0	  (C-­‐1,	  1’),	  147.4	  (C-­‐4,	  4’),	  148.9	  (C-­‐3,3’).	  EIMS	  (70	  eV)	  m/z:	  M+	  372	  (75	  %),	  177	  (5),	  152	  (87),	  151	  (100),	  137	  (11),	  121	  (13).	  HRMS	  (EI):	  m/z	  calc.	  for	  C22H28O5	  (M+)	  372.1937,	  found	  372.1938.	  	  Dehydroxycubebin	  (8R*,8’R*-­‐84)	  (3,4),(3’,4’)-­‐bis(methylenedioxy)-­‐9,9’-­‐epoxylignane	  1H-­‐NMR(300	  MHz,	   d6-­‐acetone)	   δ	   2.10–2.22	   (2H,	   m,	   H-­‐8,	   8’),	   2.50	   (2H,	   dd,	  	  
J	  =	  7.8,	  13.5,	  H-­‐7a,	  7’a),	  2.60	  (2H,	  dd,	  J	  =	  6.6,	  13.5,	  H-­‐7b,	  7’b),	  3.42	  (2H,	  dd,	  J	  =	  6.0,	  8.4,	  H-­‐9a,	  9’a),	  3.80	  (2H,	  dd,	  J	  =	  6.9,	  8.4,	  H-­‐9b,	  9’b),	  5.94	  (4H,	  dd,	  J	  =	  1.1	  Hz,	  2	  x	  	  O-­‐CH2-­‐O),	  6.61	  (2H,	  dd,	  J	  =	  1.5,	  7.8,	  H-­‐6,	  6’),	  6.65	  (2H,	  d,	  J	  =	  1.2,	  H-­‐2,	  2’),	  6.72	  (2H,	  d,	  J	  =	  7.8,	  H-­‐5,	  5’).	  13C-­‐NMR	  (125	  MHz,	  d6-­‐acetone)	  δ	  39.7	  (C-­‐7,	  7’),	  47.5	  (C-­‐8,	  8’),	  73.7	  (C-­‐9,	  9’),	  101.7	  (C-­‐10,	  10’),	  108.7	  (C-­‐5,	  5’),	  109.8	  (C-­‐2,	  2’),	  122.4	  (C-­‐6,	  6’),	  135.5	  (C-­‐1,	  1’),	  146.8	  (C-­‐4,	  4’),	  148.6	  (C-­‐3,	  3’).	  EIMS	  (70	  eV)	  m/z:	  341	  (18	  %),	  M+	  340	  (69),	  204	  (4),	  161	  (16),	  136	  (100),	  135	  (93).	  HRMS	  (EI):	  m/z	  calc.	  for	  C20H20O5	  (M+)	  340.1311,	  found	  340.1316.	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